Lista de obras - Christoph Gerlinger - Dominio Público Uruguay

0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.

artículo científico publicado en 2015

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel

artículo científico publicado en 2005

A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.

artículo científico publicado en 2005

A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density

artículo científico publicado en 2004

A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight

artículo científico publicado en 2007

A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel

scientific article published on 01 June 2000

A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, li

artículo científico publicado en 2001

A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen

artículo científico publicado en 2012

A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use ⬇️

artículo científico publicado el 1 de abril de 2003

A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel

artículo científico publicado en 2002

A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol

artículo científico publicado en 2006

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles

artículo científico publicado en 2004

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

artículo científico publicado en 2003

A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women

artículo científico publicado en 2014

An empirically generated responder definition for rosacea treatment

artículo científico publicado en 2017

An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.

artículo científico publicado en 2012

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables

artículo científico publicado en 2002

Best practice for analysis of shared clinical trial data

artículo científico publicado en 2016

Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada.

artículo científico publicado en 2009

Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 g gestodene

artículo científico publicado en 2001

Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake

artículo científico publicado en 2001

Cervical Strain Elastography in Pregnancy and Association with Maternal Factors

artículo científico publicado en 2015

Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers

artículo científico publicado en 2004

Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

artículo científico publicado en 1999

Considerations on what constitutes a 'qualified statistician' in regulatory guidelines

artículo científico publicado en 2011

Cross design analysis of randomized and observational data - application to continuation rates for a contraceptive intra uterine device containing Levonorgestrel in adolescents and adults

artículo científico publicado en 2018

Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials.

artículo científico publicado en 2010

Denial of pregnancy--characteristics of women at risk.

artículo científico publicado en 2007

Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.

artículo científico publicado en 2012

Determining the non-inferiority margin for patient reported outcomes

artículo científico publicado en 2011

Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study

artículo científico publicado en 2010

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.

artículo científico publicado en 2014

Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 microg ethinyl estradiol and 75 microg gestodene

artículo científico publicado en 2001

Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate

artículo científico publicado en 2009

Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study

artículo científico publicado en 2010

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

artículo científico publicado en 2000

Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: an open Belgian multicenter study

scientific article published on 01 October 1994

European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data

artículo científico publicado en 2013

Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries

artículo científico publicado en 2007

Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer.

artículo científico publicado en 2016

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression

artículo científico publicado en 2014

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations

artículo científico publicado en 2001

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone

artículo científico publicado en 2001

On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them

artículo científico publicado en 2006

One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women

artículo científico publicado en 2013

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestre

artículo científico publicado en 2001

Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide.

artículo científico publicado en 2011

Pattern recognition in menstrual bleeding diaries by statistical cluster analysis

artículo científico publicado en 2009

Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms

artículo científico publicado en 2014

Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women

artículo científico publicado en 2012

Recommendation for confidence interval and sample size calculation for the Pearl Index

artículo científico publicado en 2003

Recommendation for the collection and analysis of endometrial biopsies for hormone therapies.

artículo científico publicado en 2011

Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment

artículo científico publicado en 2011

Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program.

artículo científico publicado en 2015

Sperm count as a surrogate endpoint for male fertility control

artículo científico publicado en 2007

Statistical guidance for responsible data sharing: an overview

artículo científico publicado en 2016

Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials

artículo científico publicado en 2012

Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile

artículo científico publicado en 2020

Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers

artículo científico publicado en 2013

Validation of the SF-36 in patients with endometriosis

scientific article published on 13 July 2013

Lista de obras de Christoph Gerlinger

0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel

A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.

A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density

A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight

A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel

A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, li

A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen

A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use ⬇️

A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel

A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women

An empirically generated responder definition for rosacea treatment

An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables

Best practice for analysis of shared clinical trial data

Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada.

Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 g gestodene

Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake

Cervical Strain Elastography in Pregnancy and Association with Maternal Factors

Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers

Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

Considerations on what constitutes a 'qualified statistician' in regulatory guidelines

Cross design analysis of randomized and observational data - application to continuation rates for a contraceptive intra uterine device containing Levonorgestrel in adolescents and adults

Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials.

Denial of pregnancy--characteristics of women at risk.

Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.

Determining the non-inferiority margin for patient reported outcomes

Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.

Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 microg ethinyl estradiol and 75 microg gestodene

Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate

Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: an open Belgian multicenter study

European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data

Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries

Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer.

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone

On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them

One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestre

Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide.

Pattern recognition in menstrual bleeding diaries by statistical cluster analysis

Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms

Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women

Recommendation for confidence interval and sample size calculation for the Pearl Index

Recommendation for the collection and analysis of endometrial biopsies for hormone therapies.

Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment

Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program.

Sperm count as a surrogate endpoint for male fertility control

Statistical guidance for responsible data sharing: an overview

Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials

Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile

Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers

Validation of the SF-36 in patients with endometriosis